Turnstone Biologics Corp.
TSBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,447 | $51,421 | $244,076 | $244,076 |
| - Cash | $28,926 | $17,798 | $34,731 | $123,381 |
| + Debt | $1,189 | $3,214 | $5,166 | $2,683 |
| Enterprise Value | -$16,290 | $36,837 | $214,511 | $123,378 |
| Revenue | $0 | $19,306 | $73,300 | $101,293 |
| % Growth | -100% | -73.7% | -27.6% | – |
| Gross Profit | -$1,835 | $16,506 | $71,100 | $99,281 |
| % Margin | – | 85.5% | 97% | 98% |
| EBITDA | -$68,965 | -$56,234 | -$28,493 | $35,713 |
| % Margin | – | -291.3% | -38.9% | 35.3% |
| Net Income | -$70,837 | -$55,200 | -$30,834 | $33,269 |
| % Margin | – | -285.9% | -42.1% | 32.8% |
| EPS Diluted | -3.07 | -2.73 | -1.39 | 1.5 |
| % Growth | -12.5% | -96.4% | -192.7% | – |
| Operating Cash Flow | -$67,438 | -$66,152 | -$71,062 | -$45,629 |
| Capital Expenditures | -$229 | -$1,249 | -$5,170 | -$3,406 |
| Free Cash Flow | -$67,667 | -$67,401 | -$76,232 | -$49,035 |